Drug intelligence / Profile preview

homospisulosine

Development stage
Preclinical
Modality
Small Molecules
01

Overview

Homospisulosine (KP7) is a synthetic analog of **spisulosine** (1-deoxysphinganine), a sphingoid amino alcohol originally isolated from the sea clam *Spisula polynyma*. While the parent compound spisulosine demonstrated potent antiproliferative activity against a broad spectrum of solid tumors in early clinical trials, its development was hindered by significant neurotoxicity. Homospisulosine was developed as a derivative to maintain anticancer efficacy while potentially improving the therapeutic window. Preclinical studies in cervical carcinoma (HeLa) cells have shown that homospisulosine induces apoptosis through the mitochondrial pathway, evidenced by the dissipation of mitochondrial membrane potential, activation of **caspase-3**, and cleavage of **PARP**. Additionally, it has been observed to increase the levels of the cell cycle inhibitor **p27** and modulate **Bcl-2** through phosphorylation at the Ser70 residue.

Other names
homospisulosineKP7KP-7KP 7
02

Targets

CDKN1B (Transmembrane emp24 domain-containing protein 7)BCL-2 (BCL-2 family)CASP3 (Caspase-3)PARP1 (Poly (adp-ribose) polymerase 1)

Beyond the preview

Go deeper on homospisulosine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on homospisulosine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call